Actoxumab is a humanized monoclonal antibody targeting Clostridium difficile toxin A (TcdA), preventing the binding of TcdA to target cells and neutralizing toxin activity by inhibiting the first step of TcdA.
Purity:
95.00%
CAS Number:
[1245634-25-6]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted